Abstract #842660: Effect of Protein-Sparing Modified Fast Diet on Plasma Levels of Lipids, Uric Acid, and Liver Enzymes

2020 ◽  
Vol 26 ◽  
pp. 176
Author(s):  
Kenda Alkwatli
Keyword(s):  
Uric Acid ◽  
Plasma Levels ◽  
Liver Enzymes ◽  
Protein Sparing

scholarly journals Melatonin and diet-induced metabolic syndrome in rats: impact on the hypophysial-testicular axis

2013 ◽  
Vol 16 (2) ◽  
Author(s):  
Pablo A. Scacchi Bernasconi ◽  
Nancy P. Cardoso ◽  
Roxana Reynoso ◽  
Pablo Scacchi ◽  
Daniel P. Cardinali
Keyword(s):  
Metabolic Syndrome ◽  
Body Weight ◽  
Uric Acid ◽  
Plasma Levels ◽  
Density Lipoprotein ◽  
The Body ◽  
High Fat ◽  
Testosterone Secretion ◽  
Diet Manipulation ◽  
The Impact

AbstractCombinations of fructose- and fat-rich diets in experimental animals can model the human metabolic syndrome (MS). In rats, the increase in blood pressure (BP) after diet manipulation is sex related and highly dependent on testosterone secretion. However, the extent of the impact of diet on rodent hypophysial-testicular axis remains undefined. In the present study, rats drinking a 10% fructose solution or fed a high-fat (35%) diet for 10 weeks had higher plasma levels of luteinizing hormone (LH) and lower plasma levels of testosterone, without significant changes in circulating follicle-stimulating hormone or the weight of most reproductive organs. Diet manipulation brought about a significant increase in body weight, systolic BP, area under the curve (AUC) of glycemia after an intraperitoneal glucose tolerance test (IPGTT), and plasma low-density lipoprotein cholesterol, cholesterol, triglycerides, and uric acid levels. The concomitant administration of melatonin (25 μg/mL of drinking water) normalized the abnormally high LH levels but did not affect the inhibited testosterone secretion found in fructose- or high-fat-fed rats. Rather, melatonin per se inhibited testosterone secretion. Melatonin significantly blunted the body weight and systolic BP increase, the increase in the AUC of glycemia after an IPGTT, and the changes in circulating lipid profile and uric acid found in both MS models. The results are compatible with a primary inhibition of testicular function in diet-induced MS in rats and with the partial effectiveness of melatonin to counteract the metabolic but not the testicular sequelae of rodent MS.

Is idiopathic recurrent calcium urolithiasis in males a cellular disease? Laboratory findings in plasma, urine and erythrocytes, emphasizing the absence and presence of stones, oxidative and mineral metabolism: an observational study

2005 ◽  
Vol 43 (6) ◽  
Author(s):  
Paul Otto Schwille ◽  
Mahimaidos Manoharan ◽  
Angelika Schmiedl
Keyword(s):  
Ascorbic Acid ◽  
Uric Acid ◽  
Plasma Levels ◽  
Mineral Metabolism ◽  
Stone Formation ◽  
Healthy Controls ◽  
Laboratory Findings ◽  
Cross Sectional ◽  
Calcium Urolithiasis

AbstractBackground: The site of origin of idiopathic recurrent calcium urolithiasis (IRCU) – a disorder characterized by stones composed of calcium oxalate (CaOx) and/or calcium phosphate (CaPi) – is uncertain, because in urine such risk factors for stones as disturbed Ox, Ca and Pi are not regularly observed. Aims: To evaluate whether imbalance of antioxidants and oxidants might be present in IRCU patients that is then followed by abnormal urine, plasma and intracellular mineral homeostasis, and stones. Methods: Males were investigated in the laboratory under standardized conditions, and three trials were organized. Trial 1 was cross-sectional, comparing IRCU patients with (n=111) and without stones in situ (n=126), focussing on abnormalities of oxypurines and minerals in urine and plasma, and metabolic activity (MA) of the disease. Trial 2 was partly controlled (n=14 healthy subjects; n=53 IRCU patients), comparing the plasma levels of total antioxidant status (TAS) and uric acid, the major antioxidant in humans, using the subsets Low (n=26) and High (n=27) TAS among IRCU patients in terms of plasma levels of uric acid, ascorbic acid, albumin, α-tocopherol and minerals, urinary minerals, CaOx and CaPi (hydroxyapatite) supersaturation. Trial 3, comprising stone-free IRCU patients (n=8) and healthy controls (n=8), compared minerals and mineral ratios in plasma and red blood cells (RBCs). Established analytical methodologies were used throughout. Results: In trial 1, uricemia, hypoxanthinuria and proteinuria were elevated, fractional urinary clearance (FE) of uric acid was decreased in stone-bearing patients, and MA correlated positively with uricemia and urinary total protein excretion. In trial 2, TAS was significantly decreased in IRCU patients vs. healthy controls; low TAS coincided with low plasma uric acid and albumin, unchanged ascorbic acid, α-tocopherol and parathyroid hormone, but increased FE-uric acid and Pi excretion; the latter correlated negatively with TAS. In trial 3, plasma minerals were significantly decreased in IRCU patients vs. controls, and Ca/Pi, (Ca/Pi)/Mg and (Ca/Pi)/Na molar ratios increased; the latter ratio was also increased in RBCs, and correlated highly positively with the same ratio in plasma. Conclusions: In IRCU 1) renal stones in situ in combination with high fasting uricemia, high hypoxanthinuria and protein-uria, and high MA suggest that a systemic metabolic anomaly underlies stone formation; 2) antioxidant deficit is frequent, unrelated to the presence or absence of stones but apparently related to poor renal uric acid recycling, low uricemia and albuminemia, exaggerated urinary Pi excretion, and low MA; 3) the combination of low plasma TAS, disordered Ca/Pi and other mineral ratios in urine, plasma and RBCs, but unchanged urinary Ca salt supersaturation is compatible with the view that CaPi solid and Ca microlith formation start inside oxidatively damaged cells.

Cardiometabolic Risk Factors in Men with Elevated Macroprolactin Content: A Pilot Study

2019 ◽  
Vol 129 (01) ◽  
pp. 7-13
Author(s):  
Robert Krysiak ◽  
Witold Szkróbka ◽  
Bogusław Okopień
Keyword(s):  
Uric Acid ◽  
Insulin Sensitivity ◽  
Plasma Levels ◽  
Cardiometabolic Risk ◽  
Plasma Lipids ◽  
Plasma Concentrations ◽  
Hdl Cholesterol ◽  
High Sensitivity ◽  
Hydroxyvitamin D ◽  
25 Hydroxyvitamin D

Abstract Background Macroprolactinemia is a condition associated with the presence of large amounts of high molecular weight complexes of prolactin. Despite high prevalence, clinical significance of macroprolactin remains poorly understood. Objective The aim of this study was to assess cardiometabolic risk in men with isolated macroprolactinemia. Methods The study population included 11 men with isolated macroprolactinemia, 14 subjects with monomeric hyperprolactinemia and 14 men with prolactin levels within the reference range. Glucose homeostasis markers, plasma lipids, as well as plasma levels of uric acid, high-sensitivity C-reactive protein (hsCRP), fibrinogen, homocysteine and 25-hydroxyvitamin D were determined in all included patients. Results Compared to healthy counterparts, men with isolated macroprolactinemia had higher levels of 2-h postchallenge glucose, hsCRP and fibrinogen, lower levels of 25-hydroxyvitamin D and reduced insulin sensitivity. Patients with monomeric hyperprolactinemia were characterized by increased plasma levels of 2-h postchallenge glucose, triglycerides, uric acid, hsCRP, fibrinogen and homocysteine, reduced insulin sensitivity and decreased plasma concentrations of HDL cholesterol and 25-hydroxyvitamin D. Subjects with isolated macroprolactinemia differed from patients with monomeric hyperprolactinemia in postchallenge plasma glucose, insulin sensitivity, uric acid, hsCRP, fibrinogen, homocysteine and 25-hydroxyvitamin D. In men with monomeric hyperprolactinemia, uric acid, hsCRP, fibrinogen, homocysteine and 25-hydroxyvitamin D, while in men with elevated levels of macroprolactin, uric acid, hsCRP, fibrinogen and 25-hydroxyvitamin D correlated with a content of monomeric prolactin or macroprolactin, respectively, as well as with a degree of insulin sensitivity. Conclusions The obtained results suggest that macroprolactinemia may increase cardiometabolic risk but to a lesser extent than monomeric hyperprolactinemia.

One Year on Tacrine (THA): Clinical and Biochemical Effects in Patients With Dementia of the Alzheimer Type

1995 ◽  
Vol 7 (1) ◽  
pp. 75-83 ◽  
Author(s):  
Arne Åhlin ◽  
Tuula Junthé ◽  
Moustapha Hassan ◽  
Henrik Nybäck
Keyword(s):  
Side Effects ◽  
Plasma Levels ◽  
Neuropsychological Tests ◽  
Rating Scales ◽  
Liver Enzymes ◽  
Clinical Results ◽  
Dose Finding ◽  
Dose Titration ◽  
Alzheimer Type ◽  
One Year

Fourteen patients suffering from dementia of the Alzheimer type were treated with tacrine (tetrahydrominoacridine, THA) for 1 year in an open trial. Clinical results were evaluated every third month with neuropsychological tests and rating scales. During the dose-finding, two patients were temporarily withdrawn from medication and one patient was excluded because of elevated levels of liver enzymes. With individualized doses the treatment caused few side effects. Plasma levels of THA varied substantially among patients and correlated with elevation of liver enzymes but not with clinical response. Two patients showed a gradual increase in plasma levels of THA despite unchanged doses. Although results of the neuropsychological tests and clinical ratings were mostly negative, the study indicates that THA can be administered safely for prolonged periods of time. Clinical observations and dose-titration strategy in relation to side effects are discussed.

scholarly journals The effect of RNA supplementation of rat diets on the composition of body fluids

1976 ◽  
Vol 36 (3) ◽  
pp. 381-402 ◽  
Author(s):  
D. J. Heaf ◽  
J. I. Davies
Keyword(s):  
Uric Acid ◽  
Digestive Tract ◽  
Plasma Levels ◽  
Inorganic Phosphate ◽  
Body Fluids ◽  
The Body ◽  
Plasma Composition ◽  
Internal Environment ◽  
Gut Motility ◽  
Urine Composition

1. In a number of separate experiments, yeast RNA, mixtures of its constituent nucleosides, its constituent bases and ribose were administered orally to rats. In each instance, the resultant changes in the composition of body fluids were monitored using sensitive methods.2. Ingestion of RNA (100g/kg diet) caused detectable increases in intestinal ribose, inorganic phosphate, uridine, pseudouridine, uracil, inosine, uric acid and probably other purine bases. Their accumulation did not detectably affect the rate of passage of food along the digestive tract, even though some nucleosides are known to affect gut motility.3. Although plasma levels of uric acid and uridine were higher when RNA was administered in the diet, these changes were very slight compared with those in plasma uracil, which in some experiments were increased more than 20-fold compared with control levels (300μmol/l). Analysis of erythrocytes indicated that the internal environment of at least some cells of the body are similarly altered.4. Analyses indicated that all dietary RNA-phosphate passed into the urine from the gut but most of the RNA-ribose was probably metabolized. Uracil and uric acid levels in the urine reflected plasma composition.5. The effect of orally administered mixed nucleosides on blood and urine composition was similar to that of RNA, but the response to an equivalent mixture of free bases differed in several respects; cytosine, adenine and hypoxanthine appeared in urine only under these circumstances.

Five months of fasting in king penguin chicks: body mass loss and fuel metabolism

1985 ◽  
Vol 249 (4) ◽  
pp. R387-R392 ◽  
Author(s):  
Y. Cherel ◽  
Y. Le Maho
Keyword(s):  
Uric Acid ◽  
Body Mass ◽  
Plasma Concentrations ◽  
Progressive Increase ◽  
King Penguin ◽  
Body Mass Loss ◽  
Protein Utilization ◽  
Fuel Metabolism ◽  
Protein Sparing ◽  
Beta Hydroxybutyrate

When king penguin chicks are 3–4 mo old, they enter a season of interrupted growth due to long periods of fasting, because they are irregularly fed in winter. Nine captive chicks [mean initial body mass (m) = 12.5 kg] had fasted an average of 5 mo at the end of the experiment; m was then 4.0 kg, a 68% decrease. They probably could have fasted longer, since chicks of parents delayed in the return to the colony die from starvation at an m of 3.0 kg. The long fast could be divided into three periods based on the changes in rate of decrease of m. The remarkable resistance of king penguin chicks to starvation may be partly explained by their ability to maintain protein sparing for as much as 4 mo, the duration of period II; plasma concentrations of uric acid, urea, and alanine were then minimum, 0.1, 0.4, and 0.4 mmol X l–1 respectively. Particular changes during this period, i.e., progressive increase of beta-hydroxybutyrate and decrease of glucose concentrations, might contribute to the efficiency of protein sparing. Period III was marked by a rise in protein utilization, plasma concentrations of uric acid, urea, and alanine increasing to 0.7, 1.5, and 0.8 mmol X l–1, respectively.

scholarly journals Genetic Variation In Ppp1r3b And Plasma Levels Of Glucose, Lipids, And Liver Enzymes In The Danish General Population

2019 ◽  
Vol 287 ◽  
pp. e94-e95
Author(s):  
A.S. Seidelin ◽  
B.G. Nordestgaard ◽  
A. Tybjærg-Hansen ◽  
S. Stender
Keyword(s):  
Genetic Variation ◽  
General Population ◽  
Plasma Levels ◽  
Liver Enzymes

Behavioral changes in fasting emperor penguins: evidence for a “refeeding signal” linked to a metabolic shift

1998 ◽  
Vol 274 (3) ◽  
pp. R746-R753 ◽  
Author(s):  
Jean-Patrice Robin ◽  
Laurent Boucontet ◽  
Pascal Chillet ◽  
René Groscolas
Keyword(s):  
Uric Acid ◽  
Locomotor Activity ◽  
Mass Loss ◽  
Body Mass ◽  
Plasma Levels ◽  
Escape Behavior ◽  
Phase Iii ◽  
Body Mass Loss ◽  
Body Protein ◽  
Emperor Penguins

This study examines the relationships between metabolic status and behavior in spontaneously fasting birds in the context of long-term regulation of body mass and feeding. Locomotor activity, escape behavior, display songs, body mass, and metabolic and endocrine status of captive male emperor penguins were recorded during a breeding fast. We also examined whether body mass at the end of the fast affected further survival. The major part of the fast ( phase II) was characterized by the maintenance of a very low level of locomotor activity, with almost no attempt to escape, by an almost constant rate of body mass loss, and by steady plasma levels of uric acid, β-hydroxybutyrate, and corticosterone. This indicates behavioral and metabolic adjustments directed toward sparing energy and body protein. Below a body mass of ∼24 kg ( phase III), spontaneous locomotor activity and attempts to escape increased by up to 8- and 15-fold, respectively, and display songs were resumed. This probably reflected an increase in the drive to refeed. Simultaneously, daily body mass loss and plasma levels of uric acid and corticosterone increased, whereas plasma levels of β-hydroxybutyrate decreased. Some experimental birds were seen again in following years. These findings suggest that at a threshold of body mass, a metabolic and endocrine shift, possibly related to a limited availability of fat stores, acts as a “refeeding signal” that improves the survival of penguins to fasting.

Sign in / Sign up

Export Citation Format

Share Document